Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis

Intervirology

Volumn 49, Issue 6, 2006, Pages 327-338

  Moriyama, Mitsuhiko ^a   Matsumura, Hiroshi ^a   Shioda, Jiro ^a   Aoki, Hiroshi ^a   Nakamura, Hitomi ^a   Arakawa, Yasuo ^a   Nirei, Kazushige ^a   Yamagami, Hiroaki ^a   Kaneko, Miki ^a   Tanaka, Naohide ^a   Arakawa, Yasuyuki ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C viral chronic hepatitis; Hepatocellular carcinoma, prediction; Intercellular adhesion molecule 1 (ICAM 1); Liver cirrhosis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER RISK; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHRONIC HEPATITIS; ENDOPLASMIC RETICULUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; IMMUNOPEROXIDASE STAINING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN LOCALIZATION; VIRUS CARCINOGENESIS;

BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET COUNT; RISK FACTORS; RNA, VIRAL; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS C VIRUS;

EID: 33749618306     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095152     Document Type: Article

References (20)

1. Marlin SD, Springer TA: Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987;51:813-819.
2. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA: Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-933.
3. Tamatani T, Kotani M, Tanaka T, Miyasaka M: Molecular mechanisms underlying lymphocyte recirculation. II. Differential regulation of LFA-1 in the interaction between lymphocytes and high endothelial cells. Eur J Immunol 1991;21:855-858.
4. Volpes R, van den Oord JJ, Desmet VJ: Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology 1990;12:148-154.
5. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, Neuberger JM: Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991;14:426-431.
6. Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, Higuchi K, Watanabe A: Serum level of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology 1995;22:525-531.
7. Momozaki S, Yano H, Ogasawara S, Higaki K, Hisaka T, Kojiro M: Expression of intercellular adhesion molecule 1 in human hepatocellular carcinoma. Hepatology 1995;22:1708-1713.
8. Hyodo I, Jinno K, Tanimizu M, Hosokawa Y, Nishikawa Y, Akiyama M, Mandai K, Moriwaki SI: Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer 1993;55:775-779.
9. Momosaka Y, Yamada S, Harada Y, Mine S, Tsuchiya Y, Okubo H, Eto S: Change of the host immune response during the early phase of interferon therapy correlates with its long-term efficacy for chronic hepatitis C. Hepatol Res 2001;19:131-143.
10. Capra F, De Maria E, Lunardi C, Marchiori L, Mezzelani P, Beri R, Gabrielli GB: Serum level of soluble intercellular adhesion molecule 1 in patients with chronic liver disease related to hepatitis C virus: a prognostic marker for responses to interferon treatment. J Infect Dis 2000;181:425-431.
11. Ohkubo K, Kato Y, Ichikawa T, Kajiya Y, Takeda Y, Higashi S, Hamasaki K, Nakao K, Nakata K, Eguchi K: Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer 2002;94:2663-2668.
12. Levy I, Sherman M; the Liver Cancer Study Group of the University of Toronto: Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002;50:881-885.
13. Matsumura H, Moriyama M, Goto I, Tanaka N, Okubo H, Arakawa Y: Natural course of progression of liver fibrosis in Japanese patients with chronic liver disease type C - a study of 527 patients at one establishment. J Viral Hepat 2000;7:268-275.
14. Moriyama M, Matsumura H, Aoki H, Shimizu T, Nakai K, Saito T, Yamagami H, Shioda A, Kaneko M, Goto I, Tanaka N, Arakawa Y: Long-term outcome, with monitoring of platelet counts, in patients with chronic hepatitis C and liver cirrhosis after interferon therapy. Intervirology 2003;46:296-307.
15. Ono E, Shiratori Y, Okudaira T, Imamura M, Teratani T, Kanai F, Kato N, Yoshida H, Shiina S, Omata M: Platelet count reflects stage of chronic hepatitis C. Hepatol Res 1999;15:192-200.
16. Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, Higuchi K, Watanabe A: Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology 1995;22:525-531.
17. Shimizu Y, Okada K, Tsukishiro T, Minemura M, Higuchi K, Watanabe A: Modulation by cytokines on the surface expression and shedding of intercellular adhesion molecule-1 (ICAM-1) in human liver cancer cell lines. Int Hepatol Commun 1994;2:56-61.
18. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt R: Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α. J Immunol 1991;147:4398-4401.
19. Hyodo I, Jinno K, Tanimizu M, Doi T, Nishikawa Y, Hosokawa Y, Moriwaki S: Intercellular adhesion molecule-1 release from human hepatocellular carcinoma. Cancer Detect Prev 1996;20:308-315.
20. Hamazaki K, Gochi A, Shimamura H, Kaihara A, Maruo Y, Doi Y, Orita K, Lygidakis NJ: Serum levels of circulating intercellular adhesion molecule 1 in hepatocellular carcinoma. Hepatogastroenterology 1996;43:229-234.